ArticleInternational journal of clinical oncology2020

Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.

Kazuyuki Numakura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.